The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Supporting acceleration of global CVOT execution through site expertise and operational alignment
How site strategy and therapeutic expertise support faster study start-up and more consistent enrollment
Global cardiovascular outcomes trials (CVOTs) require scale, coordination, and sustained execution across regions. Early variability in site activation and enrollment can delay momentum and introduce risk.
This case study explores how aligning site strategy with experienced investigator networks and coordinating execution across teams supported faster activation and more consistent performance in a global Phase III CVOT.
Key development outcomes at a glance:
- Achieved first site activation ahead of plan
- Improved enrollment consistency across regions
- Enabled faster study momentum in early phases
What you’ll learn in this case study:
- How site selection impacts activation timelines
- Why therapeutic expertise matters at scale
- How coordinated execution supports enrollment consistency
